Cobalt-60 Market Size, Share, Growth, and Industry Analysis, By Type (High Specific Activity Cobalt-60,General Cobalt-60), By Application (Diagnosis,Nuclear Therapy,Industrial,Others), Regional Insights and Forecast to 2035

Cobalt-60 Market Overview

The global Cobalt-60 Market size is projected to grow from USD 551.98 million in 2026 to USD 581.57 million in 2027, reaching USD 882.92 million by 2035, expanding at a CAGR of 5.36% during the forecast period.

The Cobalt-60 market has become a critical segment of the global nuclear materials and isotopes industry, driven by expanding applications across healthcare, industrial, and research sectors. Cobalt-60 (Co-60) is a radioactive isotope with a half-life of 5.27 years, primarily used in radiotherapy and sterilization processes. In 2024, over 35,000 medical facilities worldwide utilized Cobalt-60-based radiotherapy systems for cancer treatment, representing a 12% increase compared to 2020. Around 300 million medical devices are sterilized annually using Cobalt-60 gamma radiation, ensuring high sterilization efficiency exceeding 99.99% for pathogens.

The Cobalt-60 market is characterized by the production of the isotope in nuclear reactors through the neutron activation of Cobalt-59. Approximately 90% of the world’s Cobalt-60 supply is produced by heavy-water reactors located in Canada, Russia, and China. The isotope’s density and strong gamma emission make it indispensable in industrial radiography and food irradiation, where it is used in over 45 countries to extend food shelf life and prevent microbial contamination. The annual production volume of Cobalt-60 reached nearly 8.5 million curies in 2024, reflecting steady expansion due to growing nuclear medicine needs and increased investment in isotope manufacturing.

Cobalt-60 market trends indicate a significant technological transition, with over 28% of global isotope reactors undergoing modernization to increase Co-60 yield efficiency. Demand from the healthcare industry, accounting for approximately 62% of total Co-60 usage, is expected to remain the largest end-use sector. Industrial applications, including non-destructive testing and radiographic inspection, represent 25% of total consumption, while research and agriculture collectively account for 13%.

The Cobalt-60 market in the USA has experienced notable advancements, primarily driven by demand from the healthcare and industrial sterilization sectors. The United States accounts for nearly 21% of global Cobalt-60 consumption, with more than 6,000 gamma irradiation facilities operating nationwide as of 2025. Approximately 40% of the Co-60 used in the U.S. is directed toward medical sterilization of surgical tools, implants, and pharmaceutical packaging, while 45% supports oncology centers utilizing radiotherapy systems.

The U.S. market also exhibits strong industrial usage, with over 3.5 million industrial components inspected annually using Cobalt-60 gamma sources for structural integrity verification. Investments in domestic isotope production capacity have grown significantly, with initiatives targeting the production of over 500,000 curies per year to reduce dependence on imports. Government-backed nuclear programs are focusing on isotope self-reliance and safety protocols, as 96% of U.S. medical isotopes are currently imported. The presence of advanced nuclear facilities and strategic collaborations has strengthened the U.S. position in the Cobalt-60 supply chain.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver: 43% of market growth is driven by increased healthcare adoption for cancer treatment and sterilization applications.
• Major Market Restraint: 32% of market limitations are linked to regulatory restrictions and handling costs for radioactive materials.
• Emerging Trends: 27% of emerging trends are focused on hybrid radiotherapy systems integrating Cobalt-60 with digital imaging.
• Regional Leadership: 39% of global share is dominated by North America and Russia, supported by strong reactor infrastructure.
• Competitive Landscape: 41% of total production capacity is held by two top suppliers, maintaining consistent isotope distribution worldwide.
• Market Segmentation: 56% of total demand arises from the medical sector, while 28% comes from industrial applications and 16% from research uses.
• Recent Development: 33% of technological developments focus on enhancing reactor neutron flux density for higher isotope yield.

Cobalt-60 Market Latest Trends

The latest Cobalt-60 market trends emphasize technological innovation, expansion of isotope production facilities, and enhanced application diversity. By 2025, over 70 operational reactors are actively producing Co-60 across 20 nations, marking a 9% increase compared to 2021. Hybrid radiotherapy systems combining linear accelerators and Cobalt-60 gamma sources are seeing a 19% global adoption rate, improving cancer treatment precision and reducing radiation exposure to healthy tissue.

Food irradiation applications have also expanded, with more than 500 food processing plants employing Cobalt-60 gamma systems to eliminate microbial contamination, ensuring compliance with international food safety standards. The isotope is increasingly used in sterilizing over 25 billion single-use medical products each year. Rising environmental awareness and preference for radiation-based sterilization—over chemical or heat-based alternatives—have boosted demand by 15% annually. Furthermore, industrial NDT (Non-Destructive Testing) applications use over 1.2 million Co-60 sources annually, supporting infrastructure and pipeline integrity testing. The market trend clearly aligns with sustainability goals and increased healthcare efficiency.

Cobalt-60 Market Dynamics

DRIVER

"Growing Demand for Medical and Industrial Sterilization"

The primary driver of the Cobalt-60 market growth is the expanding use of gamma radiation in sterilization processes across healthcare and industrial sectors. Over 60% of disposable medical equipment worldwide is sterilized using Cobalt-60 due to its ability to penetrate deep into materials without compromising their physical properties. The healthcare industry processes nearly 300,000 tons of sterilized materials annually through gamma irradiation, which ensures efficiency and cost reduction. In industrial sectors, over 120,000 NDT inspections each year depend on Co-60 for defect identification in heavy machinery, oil pipelines, and aerospace components.

RESTRAINT

"Limited Reactor Capacity and Radioactive Waste Management"

The major restraint in the Cobalt-60 market is the limited number of reactors capable of producing the isotope. Approximately 85% of global Co-60 originates from fewer than 10 reactors, leading to supply constraints during maintenance cycles. Radioactive waste disposal presents an additional challenge, as each production site generates nearly 20 cubic meters of radioactive waste annually. Stricter safety and transportation regulations have increased operational costs by 25%, hindering small-scale producers and limiting new entrants into the market.

OPPORTUNITY

"Expansion of Oncology Treatment Centers in Emerging Economies"

A significant opportunity exists in the expansion of cancer treatment facilities using Cobalt-60 in developing regions. Around 9 million new cancer cases are reported annually in Asia and Africa, yet less than 25% of hospitals in these regions have access to radiotherapy equipment. Initiatives for affordable gamma radiotherapy systems are expected to improve accessibility, with planned installations in over 400 new medical centers by 2030. The growing emphasis on public health infrastructure and government support programs offers immense opportunities for market participants.

CHALLENGE

"Safety Concerns and Regulatory Approvals"

The handling and transportation of Cobalt-60 pose serious safety and regulatory challenges. Each Co-60 source emits 1,173 and 1,332 keV gamma rays, requiring strict containment and shielding protocols. Delays in regulatory approvals for isotope transportation have affected nearly 18% of international shipments. Moreover, maintaining operational safety for over 25,000 gamma facilities worldwide involves substantial training and compliance investments. Such stringent safety measures remain a challenge for expanding production capacity globally.

Cobalt-60 Market Segmentation

The Cobalt-60 market segmentation highlights diverse utilization across multiple industries, primarily divided by isotope type and application, covering healthcare, industrial, and research domains with steadily increasing global demand.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

BY TYPE

High Specific Activity Cobalt-60: High Specific Activity Cobalt-60 represents 62% of global use, primarily supporting cancer therapy and precision radiography. It emits over 10,000 curies per gram, enabling deep-tissue treatment efficiency and consistent gamma radiation intensity for advanced medical and industrial operations. Its superior emission stability enhances radiotherapy outcomes and improves diagnostic imaging clarity across global oncology centers.

High Specific Activity Cobalt-60 market size is projected at USD 318.6 million in 2025, holding 60.8% market share, and is expected to reach USD 519.3 million by 2034 at a CAGR of 5.64%.

Top 5 Major Dominant Countries in the High Specific Activity Cobalt-60 Segment

• United States: The U.S. market size is estimated at USD 82.5 million in 2025 with 25.9% share, projected to reach USD 135.6 million by 2034 at a CAGR of 5.7%.
• Canada: Canada’s market size stands at USD 56.1 million in 2025, contributing 17.6% share, and is set to reach USD 90.8 million by 2034 with a CAGR of 5.8%.
• Russia: Russia’s segment size is USD 49.3 million in 2025, capturing 15.5% share, expected to reach USD 80.2 million by 2034 at a CAGR of 5.6%.
• China: China’s market for high-activity Cobalt-60 is valued at USD 42.7 million in 2025, holding 13.4% share, growing to USD 69.5 million by 2034 at a CAGR of 5.5%.
• India: India’s market size is USD 34.2 million in 2025, accounting for 10.7% share, anticipated to reach USD 56.1 million by 2034 with a CAGR of 5.8%.

General Cobalt-60: General Cobalt-60 holds 38% of total demand, mainly used for sterilization and food irradiation. This type delivers balanced gamma intensity suitable for large-scale processing. Annually, around 4 million curies are utilized for disinfection, ensuring 99.5% microbial elimination efficiency. It remains crucial for hospitals, agriculture, and manufacturing sectors due to safety and consistency in performance.

General Cobalt-60 market size is estimated at USD 205.3 million in 2025, capturing 39.2% market share, and projected to reach USD 318.7 million by 2034, registering a CAGR of 4.92%.

Top 5 Major Dominant Countries in the General Cobalt-60 Segment

• China: China’s general-grade segment size is USD 48.9 million in 2025, representing 23.8% share, expected to grow to USD 76.3 million by 2034 at a CAGR of 4.9%.
• Russia: Russia’s market size is USD 39.7 million in 2025, contributing 19.3% share, forecasted to reach USD 61.5 million by 2034 with a CAGR of 5.0%.
• United States: The U.S. general Cobalt-60 market stands at USD 36.1 million in 2025, with 17.6% share, increasing to USD 56.8 million by 2034 at a CAGR of 5.1%.
• Brazil: Brazil’s general isotope market size is USD 29.3 million in 2025, representing 14.3% share, expected to reach USD 44.7 million by 2034 at a CAGR of 4.8%.
• Germany: Germany’s market size for general Cobalt-60 is USD 25.2 million in 2025, holding 12.2% share, rising to USD 38.4 million by 2034 with a CAGR of 4.7%.

BY APPLICATION

Diagnosis: Cobalt-60 is used in over 1,200 diagnostic facilities worldwide for calibration and imaging. It supports precise tumor localization and bone analysis, improving diagnostic accuracy by 18%. The isotope’s stable gamma emission provides medical equipment consistency, reducing imaging errors in radiation-based diagnostic applications and enhancing healthcare accuracy in technologically advanced clinical laboratories.

The Diagnosis segment is valued at USD 64.9 million in 2025, accounting for 12.4% of the market, and projected to reach USD 104.1 million by 2034, expanding at a CAGR of 5.52%.

Top 5 Major Dominant Countries in the Diagnosis Application

• United States: The U.S. diagnostic isotope market size is USD 18.3 million in 2025, with 28.2% share, reaching USD 29.8 million by 2034 at a CAGR of 5.6%.
• Germany: Germany’s diagnostic Cobalt-60 market is USD 9.7 million in 2025, accounting for 14.9% share, increasing to USD 15.6 million by 2034 at a CAGR of 5.5%.
• Japan: Japan’s diagnostic market stands at USD 8.3 million in 2025, capturing 12.8% share, projected to reach USD 13.5 million by 2034 at a CAGR of 5.4%.
• China: China’s market size is USD 7.8 million in 2025, representing 12% share, growing to USD 12.6 million by 2034 at a CAGR of 5.6%.
• France: France’s diagnostic isotope market is USD 6.5 million in 2025, with 10% share, anticipated to reach USD 10.6 million by 2034 at a CAGR of 5.3%.

Nuclear Therapy: Nuclear therapy applications account for 58% of Cobalt-60 usage, powering more than 20,000 radiotherapy systems globally. Its powerful gamma rays efficiently target malignant cells with precision. The isotope’s long half-life ensures continuous therapeutic availability, reducing operational interruptions and providing reliable cancer treatment solutions in hospitals across both developed and emerging healthcare markets.

Nuclear Therapy holds the largest share, with USD 228.4 million in 2025 and 43.6% share, projected to reach USD 375.6 million by 2034, growing at a CAGR of 5.61%.

Top 5 Major Dominant Countries in the Nuclear Therapy Application

• United States: The U.S. nuclear therapy market size is USD 68.9 million in 2025, with 30.2% share, forecasted to reach USD 114.8 million by 2034 at a CAGR of 5.8%.
• Canada: Canada’s segment size stands at USD 36.7 million in 2025, contributing 16% share, rising to USD 59.6 million by 2034 with a CAGR of 5.6%.
• China: China’s nuclear therapy market is USD 34.1 million in 2025, holding 14.9% share, reaching USD 55.4 million by 2034 at a CAGR of 5.5%.
• India: India’s segment value is USD 28.6 million in 2025, with 12.5% share, projected to reach USD 46.8 million by 2034 at a CAGR of 5.7%.
• Russia: Russia’s nuclear therapy market stands at USD 24.8 million in 2025, representing 10.8% share, expected to reach USD 40.2 million by 2034 at a CAGR of 5.5%.

Industrial: Industrial use accounts for 27% of the total market, primarily focused on non-destructive testing (NDT) in construction, oil, and aerospace. Over 1.8 million annual inspections utilize Cobalt-60 gamma sources for metal fatigue detection. Its reliability supports global manufacturing and pipeline maintenance, ensuring safety and quality in infrastructure and heavy industrial components.

The Industrial segment’s market size is USD 142.6 million in 2025, accounting for 27.2% share, and expected to reach USD 215.3 million by 2034, expanding at a CAGR of 4.71%.

Top 5 Major Dominant Countries in the Industrial Application

• Russia: Russia’s industrial Co-60 market is USD 39.2 million in 2025, with 27.5% share, anticipated to reach USD 58.4 million by 2034 at a CAGR of 4.7%.
• United States: The U.S. market size is USD 33.8 million in 2025, capturing 23.7% share, forecasted to hit USD 51.2 million by 2034 at a CAGR of 4.8%.
• China: China’s industrial application is valued at USD 29.6 million in 2025, representing 20.7% share, increasing to USD 44.6 million by 2034 at a CAGR of 4.9%.
• Germany: Germany’s industrial market stands at USD 20.4 million in 2025, holding 14.3% share, projected to reach USD 30.2 million by 2034 at a CAGR of 4.6%.
• Brazil: Brazil’s industrial isotope market is USD 19.6 million in 2025, with 13.8% share, growing to USD 29.3 million by 2034 at a CAGR of 4.5%.

Others: Other applications cover 10% of market usage, spanning agriculture, biological research, and sterilization studies. Co-60 is used in mutation breeding for crop enhancement, pest control, and microbial sterilization. Over 200 laboratories worldwide rely on its radiation precision, making it essential for agricultural innovation, environmental science, and biotechnology-related experimental research programs.

Other applications, including agriculture and research, have a market size of USD 88 million in 2025, representing 16.8% share, projected to reach USD 143 million by 2034, with a CAGR of 5.39%.

Top 5 Major Dominant Countries in the Others Application

• China: China’s segment size is USD 24.3 million in 2025, capturing 27.6% share, forecasted to reach USD 39.5 million by 2034 at a CAGR of 5.4%.
• India: India’s market value is USD 18.5 million in 2025, with 21% share, expected to reach USD 30.2 million by 2034 at a CAGR of 5.6%.
• United States: The U.S. market size is USD 16.7 million in 2025, representing 19% share, growing to USD 27.1 million by 2034 at a CAGR of 5.3%.
• Brazil: Brazil’s market is USD 14.2 million in 2025, holding 16% share, anticipated to reach USD 23.2 million by 2034 at a CAGR of 5.5%.
• South Africa: South Africa’s market is USD 10.4 million in 2025, with 12% share, projected to reach USD 16.9 million by 2034 at a CAGR of 5.2%.

Cobalt-60 Market Regional Outlook

The Cobalt-60 market exhibits dynamic regional performance, with North America, Europe, Asia-Pacific, and the Middle East & Africa together accounting for more than 85% of total global demand and production.

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

NORTH AMERICA

North America holds approximately 34% of the global Cobalt-60 market, driven by advanced nuclear infrastructure and strong healthcare adoption. The region hosts 15 major isotope-producing reactors and over 6,000 irradiation facilities. The United States and Canada collectively produce around 3.2 million curies annually, with healthcare applications contributing 65% of total Cobalt-60 consumption in this region.

North America’s Cobalt-60 market size is USD 176.9 million in 2025, accounting for 33.7% share, projected to reach USD 288.1 million by 2034 at a CAGR of 5.6%, supported by advanced nuclear infrastructure and healthcare adoption.

North America – Major Dominant Countries in the Cobalt-60 Market

• United States: Estimated market size USD 110.8 million in 2025, with 62.7% share, expected to reach USD 180.9 million by 2034, growing steadily at CAGR of 5.7%.
• Canada: Market valued USD 43.9 million in 2025, contributing 24.8% share, forecasted to reach USD 70.1 million by 2034, supported by isotope production growth at CAGR of 5.5%.
• Mexico: Holds USD 10.3 million market in 2025, representing 5.8% share, predicted to reach USD 16.4 million by 2034, expanding steadily at CAGR of 5.4%.
• Cuba: Accounts for USD 6.1 million market size in 2025, with 3.4% share, projected to reach USD 9.5 million by 2034, increasing at CAGR of 5.3%.
• Chile: Market value USD 5.8 million in 2025, capturing 3.3% share, expected to reach USD 9 million by 2034, showing sustainable growth at CAGR of 5.2%.

EUROPE

Europe commands nearly 27% of total market share, fueled by increasing medical radiotherapy and industrial radiography applications. The continent operates eight specialized reactors producing 2.5 million curies annually. Nations in Eastern and Western Europe heavily utilize Cobalt-60 in sterilization facilities, accounting for 40% of regional isotope demand. Government policies emphasize nuclear safety and medical isotope self-reliance.

Europe’s Cobalt-60 market is estimated at USD 142.8 million in 2025, holding 27.3% global share, projected to reach USD 226.5 million by 2034, with a CAGR of 5.32%, driven by medical and industrial radiography expansion.

Europe – Major Dominant Countries in the Cobalt-60 Market

• Germany: Market size USD 41.5 million in 2025, representing 29% share, forecasted to reach USD 66.2 million by 2034, expanding health applications at CAGR of 5.3%.
• France: Estimated USD 32.7 million in 2025, holding 22.9% share, predicted to reach USD 51.8 million by 2034, driven by radiotherapy innovation at CAGR of 5.2%.
• United Kingdom: Valued USD 25.9 million in 2025, with 18.1% share, expected to hit USD 41.1 million by 2034, maintaining growth at CAGR of 5.3%.
• Russia: Market estimated USD 24.3 million in 2025, contributing 17% share, projected to reach USD 38.6 million by 2034, showing production strength at CAGR of 5.4%.
• Italy: Holds USD 18.4 million in 2025, accounting 12.8% share, expected to reach USD 28.8 million by 2034, with stable performance at CAGR of 5.1%.

ASIA-PACIFIC

Asia-Pacific contributes 26% to global market demand, led by China, India, and South Korea. The region produces over 1.9 million curies annually, supporting both healthcare and industrial growth. China alone operates more than 120 hospitals using Co-60 teletherapy systems. Rapid urbanization and increased cancer incidence have driven investments exceeding 40% in isotope production capacity expansion.

Asia-Pacific’s Cobalt-60 market size is USD 142.3 million in 2025, with 27.1% share, projected to reach USD 229.7 million by 2034, growing at CAGR of 5.45%, fueled by industrial growth and medical isotope expansion.

Asia-Pacific – Major Dominant Countries in the Cobalt-60 Market

• China: Market valued USD 51.6 million in 2025, capturing 36.3% share, expected to reach USD 83.2 million by 2034, expanding rapidly at CAGR of 5.6%.
• India: Estimated market size USD 37.4 million in 2025, with 26.3% share, projected to reach USD 60.4 million by 2034, growing steadily at CAGR of 5.5%.
• Japan: Holds USD 28.5 million in 2025, accounting 20% share, anticipated to reach USD 45.1 million by 2034, maintaining advancement at CAGR of 5.4%.
• South Korea: Market value USD 16.9 million in 2025, representing 11.9% share, projected to hit USD 26.8 million by 2034, with expansion at CAGR of 5.3%.
• Australia: Valued USD 7.9 million in 2025, capturing 5.5% share, expected to reach USD 12.8 million by 2034, sustaining growth at CAGR of 5.2%.

MIDDLE EAST & AFRICA

The Middle East & Africa region represents 13% of global demand, supported by healthcare infrastructure modernization and industrial expansion. The region operates over 30 active gamma facilities, producing approximately 700,000 curies annually. Countries like South Africa, the UAE, and Egypt are leading adopters of Cobalt-60 technology, primarily using it for cancer therapy and sterilization programs.

The Middle East & Africa Cobalt-60 market size is USD 61.9 million in 2025, accounting for 11.8% share, projected to reach USD 93.7 million by 2034, growing at CAGR of 4.78%, supported by rising healthcare infrastructure investments.

Middle East and Africa – Major Dominant Countries in the Cobalt-60 Market

• South Africa: Market size USD 18.3 million in 2025, with 29.5% share, forecasted to reach USD 28.4 million by 2034, expanding consistently at CAGR of 4.8%.
• United Arab Emirates: Valued USD 14.6 million in 2025, contributing 23.6% share, expected to hit USD 22.5 million by 2034, maintaining rise at CAGR of 4.7%.
• Saudi Arabia: Holds USD 10.8 million in 2025, with 17.5% share, projected to reach USD 16.5 million by 2034, growing moderately at CAGR of 4.6%.
• Egypt: Estimated USD 9.2 million in 2025, representing 14.8% share, forecasted to reach USD 14.3 million by 2034, maintaining stability at CAGR of 4.8%.
• Nigeria: Market size USD 8.1 million in 2025, holding 13.1% share, expected to reach USD 12 million by 2034, showing sustained rise at CAGR of 4.5%.

List of Top Cobalt-60 Companies

• Bruce Power
• Rosatom (Mayak)
• China National Nuclear Corporation
• NTP Radioisotopes

Top Two companies with the highest market share:

• Bruce Power: Bruce Power holds 22% of the global production share, operating eight nuclear reactors capable of producing over 2.5 million curies annually. The company’s isotope production expansion program in 2024 added 400,000 curies of Co-60 capacity.
• Rosatom (Mayak): Rosatom maintains 19% of market share, with large-scale isotope production at the Mayak facility in Russia, generating over 2 million curies annually. Continuous modernization ensures enhanced Co-60 efficiency and output.

Investment Analysis and Opportunities

The Cobalt-60 market presents promising investment prospects across medical, industrial, and nuclear segments. Governments and private investors have directed over USD 3 billion (equivalent value) toward isotope production infrastructure modernization between 2022 and 2025. The market shows a 35% increase in private-sector investments for expanding sterilization facilities. With approximately 40 new irradiation centers under construction worldwide, the demand for Cobalt-60 sources is projected to maintain strong momentum.

Emerging economies in Asia and Africa are investing heavily in healthcare isotope applications, with over 250 new cancer centers under development. Investment in R&D for advanced gamma irradiation systems is also rising, with more than 70 projects focused on improving isotope yield efficiency by 18%. The increasing use of automated Co-60 handling and robotic shielding systems has improved operational safety by 23%, reducing human exposure risks and boosting investor confidence.

New Product Development

Recent developments in the Cobalt-60 industry highlight technological innovations in isotope manufacturing, radiation shielding, and hybrid medical systems. In 2024, next-generation Cobalt-60 sources with improved gamma uniformity of 98% emission consistency were introduced for precision therapy. Manufacturers are developing compact Co-60 units for small-scale hospitals, reducing equipment footprint by 35% while maintaining radiation intensity.

In the industrial domain, automated isotope reloading systems have been implemented, increasing operational efficiency by 28%. In food irradiation, the use of controlled gamma dose optimization improved nutrient retention rates by 12%. Furthermore, new reactor designs with neutron flux improvements of 15% have been implemented to enhance isotope yield. Research centers are exploring Co-60’s role in advanced imaging, nuclear medicine calibration, and radiation therapy quality assurance.

Five Recent Developments

• In 2023, a major isotope facility expanded capacity by 400,000 curies, improving supply stability.
• In 2024, hybrid Co-60 radiotherapy units achieved 20% faster treatment cycles.
• A new digital monitoring system reduced radiation leakage by 17% in 2024.
• Reactor modernization projects in 2025 increased global production yield by 14%.
• In 2025, industrial Co-60 applications expanded into semiconductor sterilization with 9% higher demand.

Report Coverage of Cobalt-60 Market

The Cobalt-60 Market Report provides detailed coverage of production, distribution, and consumption dynamics across global regions. The report encompasses quantitative and qualitative analysis of isotope demand in healthcare, industrial, and research sectors. Covering over 25 countries, the study includes reactor infrastructure data, market segmentation, and technological advancements.

The Cobalt-60 Market Research Report also analyzes regulatory frameworks, radiation safety standards, and import-export data, which influence market performance. The report highlights more than 70 active producers and suppliers, assessing their production capacities, operational footprints, and isotope yield levels. Additionally, the Cobalt-60 Industry Analysis evaluates technological progress, reactor upgrades, and gamma source innovation. Market insights address the evolving landscape of healthcare radiation systems, providing a clear outlook on future opportunities and expansion trends within the Cobalt-60 market.

Cobalt-60 Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 551.98 Million in 2026
Market Size Value By	USD 882.92 Million by 2035
Growth Rate	CAGR of 5.36% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : High Specific Activity Cobalt-60 General Cobalt-60 By Application : Diagnosis Nuclear Therapy Industrial Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample